Murphy Pohlad Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.26M | Sell |
52,377
-5,560
| -10% | -$145K | 0.44% | 69 |
|
|
2026
Q1 | $1.63M | Sell |
57,937
-4,858
| -8% | -$129K | 0.58% | 56 |
|
|
2025
Q4 | $1.56M | Sell |
62,795
-19,641
| -24% | -$495K | 0.6% | 57 |
|
|
2025
Q3 | $2.1M | Sell |
82,436
-34,459
| -29% | -$851K | 0.82% | 45 |
|
|
2025
Q2 | $2.83M | Sell |
116,895
-7,070
| -6% | -$165K | 1.2% | 36 |
|
|
2025
Q1 | $3.14M | Buy |
123,965
+8,740
| +8% | +$229K | 1.33% | 30 |
|
|
2024
Q4 | $3.06M | Sell |
115,225
-31,044
| -21% | -$842K | 1.32% | 34 |
|
|
2024
Q3 | $4.23M | Buy |
146,269
+12,645
| +9% | +$369K | 1.76% | 15 |
|
|
2024
Q2 | $3.74M | Buy |
133,624
+6,000
| +5% | +$165K | 1.61% | 21 |
|
|
2024
Q1 | $3.54M | Sell |
127,624
-1,205
| -0.9% | -$33.4K | 1.39% | 28 |
|
|
2023
Q4 | $3.71M | Buy |
128,829
+1,850
| +1% | +$55.9K | 1.53% | 26 |
|
|
2023
Q3 | $4.21M | Buy |
126,979
+10,415
| +9% | +$368K | 1.85% | 19 |
|
|
2023
Q2 | $4.28M | Buy |
116,564
+5,450
| +5% | +$212K | 1.84% | 18 |
|
|
2023
Q1 | $4.53M | Buy |
111,114
+265
| +0.2% | +$11.4K | 1.88% | 19 |
|
|
2022
Q4 | $5.68M | Buy |
110,849
+1,042
| +0.9% | +$50K | 2.32% | 9 |
|
|
2022
Q3 | $4.8M | Buy |
109,807
+2,098
| +2% | +$102K | 2.22% | 12 |
|
|
2022
Q2 | $5.65M | Buy |
107,709
+1,580
| +1% | +$80.5K | 2.48% | 7 |
|
|
2022
Q1 | $5.49M | Buy |
106,129
+2,950
| +3% | +$153K | 2.21% | 13 |
|
|
2021
Q4 | $6.09M | Sell |
103,179
-100
| -0.1% | -$4.96K | 2.4% | 7 |
|
|
2021
Q3 | $4.44M | Buy |
103,279
+3,200
| +3% | +$142K | 1.81% | 17 |
|
|
2021
Q2 | $3.92M | Buy |
100,079
+3,647
| +4% | +$142K | 1.59% | 22 |
|
|
2021
Q1 | $3.49M | Buy |
96,432
+3,840
| +4% | +$136K | 1.52% | 25 |
|
|
2020
Q4 | $3.41M | Buy |
92,592
+26,019
| +39% | +$954K | 1.69% | 19 |
|
|
2020
Q3 | $2.32M | Buy |
66,573
+7,273
| +12% | +$255K | 1.23% | 32 |
|
|
2020
Q2 | $1.84M | Buy |
59,300
+5,908
| +11% | +$201K | 1.03% | 43 |
|
|
2020
Q1 | $1.65M | Buy |
53,392
+3,414
| +7% | +$116K | 1.13% | 40 |
|
|
2019
Q4 | $1.86M | Buy |
49,978
+2,130
| +4% | +$75.9K | 1.02% | 41 |
|
|
2019
Q3 | $1.63M | Buy |
47,848
+780
| +2% | +$28.4K | 1% | 43 |
|
|
2019
Q2 | $1.93M | Sell |
47,068
-949
| -2% | -$37.7K | 1.16% | 36 |
|
|
2019
Q1 | $1.93M | Sell |
48,017
-5,402
| -10% | -$216K | 1.17% | 41 |
|
|
2018
Q4 | $2.21M | Sell |
53,419
-2,071
| -4% | -$86K | 1.54% | 21 |
|
|
2018
Q3 | $2.32M | Sell |
55,490
-11,894
| -18% | -$458K | 1.43% | 30 |
|
|
2018
Q2 | $2.32M | Sell |
67,384
-3,284
| -5% | -$112K | 1.55% | 26 |
|
|
2018
Q1 | $2.38M | Sell |
70,668
-1,966
| -3% | -$67.6K | 1.64% | 23 |
|
|
2017
Q4 | $2.5M | Sell |
72,634
-2,656
| -4% | -$90.6K | 1.65% | 20 |
|
|
2017
Q3 | $2.55M | Buy |
75,290
+1,981
| +3% | +$63.7K | 1.77% | 21 |
|
|
2017
Q2 | $2.34M | Sell |
73,309
-5,469
| -7% | -$172K | 1.72% | 20 |
|
|
2017
Q1 | $2.56M | Sell |
78,778
-2,086
| -3% | -$65.8K | 1.89% | 18 |
|
|
2016
Q4 | $2.49M | Buy |
80,864
+16,037
| +25% | +$490K | 1.8% | 20 |
|
|
2016
Q3 | $2.08M | Buy |
64,827
+2,492
| +4% | +$83.3K | 1.55% | 27 |
|
|
2016
Q2 | $2.08M | Hold |
62,335
| – | – | 1.55% | 23 |
|
|
2016
Q1 | $1.75M | Buy |
62,335
+7,073
| +13% | +$202K | 1.32% | 30 |
|
|
2015
Q4 | $1.69M | Hold |
55,262
| – | – | 1.34% | 31 |
|
|
2015
Q3 | $1.65M | Hold |
55,262
| – | – | 1.34% | 35 |
|
|
2015
Q2 | $1.76M | Hold |
55,262
| – | – | 1.32% | 35 |
|
|
2015
Q1 | $1.82M | Sell |
55,262
-55,289
| -50% | -$1.76M | 1.4% | 35 |
|
|
2014
Q4 | $3.27M | Sell |
110,551
-1,101
| -1% | -$31.6K | 2.36% | 10 |
|
|
2014
Q3 | $3.13M | Hold |
111,652
| – | – | 2.43% | 10 |
|
|
2014
Q2 | $3.14M | Sell |
111,652
-2,003
| -2% | -$57.1K | 2.41% | 11 |
|
|
2014
Q1 | $3.46M | Sell |
113,655
-2,224
| -2% | -$66.3K | 2.81% | 5 |
|
|
2013
Q4 | $3.37M | Sell |
115,879
-9,775
| -8% | -$284K | 2.75% | 8 |
|
|
2013
Q3 | $3.42M | Sell |
125,654
-2,956
| -2% | -$80.4K | 3.06% | 4 |
|
|
2013
Q2 | $3.42M | Buy |
+128,610
| New | +$3.55M | 3.16% | 4 |
|
Other funds holding PFE
Murphy Pohlad Asset Management's PFE Position: Q2 2026 in Review
Murphy Pohlad Asset Management reduced its Pfizer (PFE) stake by 9.6% in Q2 2026, selling an estimated $145K and leaving 52,377 shares worth $1.26M. The position accounts for 0.44% of the portfolio, ranked #69.
Murphy Pohlad Asset Management first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $6.09M in Q4 2021. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Murphy Pohlad Asset Management held 52,377 shares of Pfizer worth $1.26M as of Q2 2026.
- Murphy Pohlad Asset Management sold 5,560 Pfizer shares in Q2 2026, an estimated $145K.
- Pfizer made up 0.44% of Murphy Pohlad Asset Management's portfolio in Q2 2026, its #69 holding.
- Murphy Pohlad Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Murphy Pohlad Asset Management's Pfizer position peaked at $6.09M in Q4 2021.
- 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Murphy Pohlad Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.